Anti-EBAG9

Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-R31790 100 µg - -

3 - 10 Werktage*

790,00 €
 
0.5mg/ml if reconstituted with 0.2ml sterile DI water. Receptor-binding cancer antigen expressed... mehr
Produktinformationen "Anti-EBAG9"
0.5mg/ml if reconstituted with 0.2ml sterile DI water. Receptor-binding cancer antigen expressed on SiSo cells is a protein that in humans is encoded by the EBAG9 gene. This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. And the encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. Protein function: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1- beta converting enzyme (ICE)-like proteases. [The UniProt Consortium]
Schlagworte: Anti-RCAS1, Anti-EBAG9, Anti-Cancer-associated surface antigen RCAS1, Anti-Receptor-binding cancer antigen expressed on SiSo cells, Anti-Estrogen receptor-binding fragment-associated gene 9 protein, EBAG9 Antibody
Hersteller: NSJ Bioreagents
Hersteller-Nr: R31790

Eigenschaften

Anwendung: WB, IHC (paraffin)
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human, mouse, rat
Immunogen: Amino acids 31-213 of human EBAG9 were used as the immunogen for the EBAG9 antibody.
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-EBAG9"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen